Hannu Kankaanranta

Medicine & Life Sciences

1. Asthma 100%
2. Finland 35%
3. Sweden 29%
4. Population 20%
5. Estonia 19%
6. Chronic Obstructive Pulmonary Disease 17%
7. Adrenal Cortex Hormones 14%
8. Social Class 12%
9. Smoking 12%
10. 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole 11%
11. Odds Ratio 11%
12. Dust 10%
13. Occupational Exposure 10%
14. Cross-Sectional Studies 10%
15. Dyspnea 10%
16. Multimorbidity 9%
17. Urokinase Plasminogen Activator Receptors 9%
18. Genome-Wide Association Study 8%
19. Bronchodilator Agents 8%
20. Rhinitis 8%
21. Life Style 8%
22. Gases 8%
23. Fees and Charges 8%
24. Physicians 8%
25. Idiopathic Pulmonary Fibrosis 7%
26. Agriculture 7%
27. Eczema 7%
28. Women's Health 7%
29. Treatment Adherence and Compliance 7%
30. Sleep Apnea Syndromes 7%
31. Biomarkers 7%
32. Obstructive Sleep Apnea 6%
33. Smoke 6%
34. Tobacco 6%
35. Occupations 6%
36. Hematopoietic Stem Cells 6%
37. Intraocular Pressure 6%
38. Habits 6%
39. Glaucoma 6%
40. Cough 5%
41. Statistical Factor Analysis 5%
42. Scandinavian and Nordic Countries 5%
43. Non-Steroidal Anti-Inflammatory Agents 5%
44. Registries 5%